Shanghai Shen Lian Biomedical Corporation (SHA:688098)

Market Cap	3.58B +58.3%
Revenue (ttm)	288.27M -5.0%
Net Income	-19.09M
EPS	-0.05
Shares Out	410.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,692,521
Average Volume	9,599,425
Open	8.89
Previous Close	8.90
Day's Range	8.66 - 8.91
52-Week Range	5.31 - 17.57
Beta	0.74
RSI	44.79
Earnings Date	Apr 29, 2026

About SHA:688098

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 374
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688098

Financial Performance

In 2025, SHA:688098's revenue was 288.27 million, a decrease of -4.99% compared to the previous year's 303.41 million. Losses were -19.09 million, -57.33% less than in 2024.